[go: up one dir, main page]

NO961297L - Ranitidine og kalsiumkarbonat farmasöytisk produkt - Google Patents

Ranitidine og kalsiumkarbonat farmasöytisk produkt

Info

Publication number
NO961297L
NO961297L NO961297A NO961297A NO961297L NO 961297 L NO961297 L NO 961297L NO 961297 A NO961297 A NO 961297A NO 961297 A NO961297 A NO 961297A NO 961297 L NO961297 L NO 961297L
Authority
NO
Norway
Prior art keywords
calcium carbonate
ranitidine
pharmaceutical product
carbonate pharmaceutical
pharmaceutical preparation
Prior art date
Application number
NO961297A
Other languages
English (en)
Other versions
NO961297D0 (no
Inventor
Mark Alan Sirgo
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of NO961297L publication Critical patent/NO961297L/no
Publication of NO961297D0 publication Critical patent/NO961297D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytisk preparat for mage/tarmtilstander omfattende ranitidin og kalsiumkarbonat.
NO961297A 1993-09-30 1996-03-29 Ranitidine og kalsiumkarbonat farmasöytisk produkt NO961297D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12951793A 1993-09-30 1993-09-30
PCT/US1994/011132 WO1995008997A1 (en) 1993-09-30 1994-09-29 Ranitidine and calcium carbonate pharmaceutical combination product

Publications (2)

Publication Number Publication Date
NO961297L true NO961297L (no) 1996-03-29
NO961297D0 NO961297D0 (no) 1996-03-29

Family

ID=22440376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961297A NO961297D0 (no) 1993-09-30 1996-03-29 Ranitidine og kalsiumkarbonat farmasöytisk produkt

Country Status (17)

Country Link
EP (1) EP0721338A1 (no)
JP (1) JPH09503212A (no)
CN (1) CN1140996A (no)
AU (1) AU677108B2 (no)
BG (1) BG100456A (no)
CA (1) CA2168846A1 (no)
CZ (1) CZ76996A3 (no)
HU (1) HUT75061A (no)
IL (1) IL111094A0 (no)
NO (1) NO961297D0 (no)
NZ (1) NZ274713A (no)
OA (1) OA10717A (no)
PL (1) PL316855A1 (no)
SG (1) SG44715A1 (no)
SK (1) SK40596A3 (no)
WO (1) WO1995008997A1 (no)
ZA (1) ZA947553B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5560701B2 (ja) * 2008-12-26 2014-07-30 ライオン株式会社 ラニチジン含有医薬固形製剤及びラニチジン担持粒子の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230701A (en) * 1988-09-20 1992-01-29 Glaxo Group Ltd Pharmaceutical compositions comprising ranitidine, alginic acid and a carbonate or bicarbonate
JPH05507695A (ja) * 1990-06-22 1993-11-04 ビーチャム グループ ピーエルシー 新規な治療
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
CN1140996A (zh) 1997-01-22
NZ274713A (en) 1997-10-24
HU9600810D0 (en) 1996-05-28
ZA947553B (en) 1995-05-26
CA2168846A1 (en) 1995-04-06
HUT75061A (en) 1997-03-28
JPH09503212A (ja) 1997-03-31
AU7925394A (en) 1995-04-18
SG44715A1 (en) 1997-12-19
WO1995008997A1 (en) 1995-04-06
OA10717A (en) 2002-12-09
SK40596A3 (en) 1997-02-05
IL111094A0 (en) 1994-11-28
NO961297D0 (no) 1996-03-29
EP0721338A1 (en) 1996-07-17
BG100456A (en) 1996-11-29
CZ76996A3 (en) 1996-10-16
AU677108B2 (en) 1997-04-10
PL316855A1 (en) 1997-02-17

Similar Documents

Publication Publication Date Title
IS1846B (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
NO993519L (no) Fenofibrat farmasöytisk blanding som har höy biotilgjengelighet og fremgangsmÕte for fremstilling av den
NO976048D0 (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
AU6948994A (en) Iron-binding polymers for oral administration
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
IS2457B (is) Samsetningar af lyfjum (t.d. klórprómasíni og pentamídíni) fyrir meðhöndlun á æxlistruflunum
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
NO953657L (no) Nytt farmasöytisk produkt
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
PL356904A1 (en) Pharmaceutical compositions
DE69419295D1 (de) Zweifach gegossenes Produkt
NO965102D0 (no) Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
IS5366A (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
JO2017B1 (en) Pharmaceutical formula for infectious residence
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.
BR0203501A (pt) Formulações de multipartìculas biomoduladas
NO961297L (no) Ranitidine og kalsiumkarbonat farmasöytisk produkt
IT1289883B1 (it) Composizione farmaceutica antitubercolare e procedimento per la sua produzione
NO980471D0 (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
DE69723873D1 (de) Kristallines pharmazeutisches produkt
DZ2159A1 (fr) Produits pharmaceutiques.
ITRM940140A0 (it) Procedimento e dispositivo per la produzione di potassa.
NL1000767A1 (nl) Granulatie-apparatuur, granulatieprocedure en gegranuleerd produkt.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application